Patent Assignment
Reel/Frame 074878/0973
Security Interest
Recorded: 2026-02-17
Pages: 23
Assignor
IMMUNOBRAIN CHECKPOINT, INC.
Executed: 2025-07-15
Assignee
RVIBC LENDER LLC
1301 AVENUE OF THE AMERICAS, FLOOR 15, NEW YORK, NEW YORK, 10019
Covered Properties
(42)
Modified Anti-Pd-L1 Antibody and Methods and Uses for Treating a Neurodegenerative Disease
Modified Anti-Pd-L1 Antibody and Methods and Uses for Treating a Neurodegenerative Disease
Modified Anti-Pd-L1 Antibody and Methods and Uses for Treating a Neurodegenerative Disease
Application:
18/360,222 →
Publication:
US 2024/0052038
Modified Anti-Pd-L1 Antibody and Methods and Uses for Treating a Neurodegenerative Disease
Application:
62/836,247 →
Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Disease and Injury of the Cns
Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Alzheimer's Disease
Patent:
9,394,365 →
Application:
14/957,065 →
Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Alzheimer's Disease
Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Alzheimer's Disease
Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Alzheimer's Disease
Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Disease and Injury of the Cns
Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Alzheimer's Disease
Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Alzheimer's Disease
Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Alzheimer's Disease
Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Alzheimer's Disease
Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Disease and Injury of the Cns
Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Amyotrophic Lateral Sclerosis
Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Disease and Injury of the Cns
Application:
61/951,783 →
Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Disease and Injury of the Cns
Application:
62/030,164 →
Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Disease and Injury of the Cns
Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Disease and Injury of the Cns
Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Disease and Injury of the Cns
Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Amyotrophic Lateral Sclerosis
Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Disease and Injury of the Cns
Application:
18/535,960 →
Publication:
US 2024/0182566
Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Disease and Injury of the Cns
Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of a Retinal Degeneration Disorder
Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Retinal Degeneration
Application:
62/279,622 →
Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Disease and Injury of the Cns
Application:
62/353,549 →
Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Disease and Injury of the Cns
Application:
62/358,530 →
Individualized Immunomodulation Therapy for Neurodegenerative Disorders, Cns Injury and Age-Related Dementia
Application:
14/427,089 →
Publication:
US 2015/0238582
Individualized Immunomodulation Therapy for Neurodegenerative Disorders, Cns Injury and Age-Related Dementia
Application:
16/145,641 →
Publication:
US 2019/0022198
Ns-Specific Antigens, Peptides and Analogs Thereof for Treating Amyotrophic Lateral Sclerosis
Application:
61/779,440 →
Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Disease and Injury of the Cns
Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Disease and Injury of the Cns
Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Disease and Injury of the Cns
Application:
17/806,187 →
Publication:
US 2023/0183350
Biomarkers for Cns Disease Modification
Application:
17/423,769 →
Publication:
US 2022/0146534
Biomarkers for Neurodegenerative Disease
Application:
18/557,941 →
Publication:
US 2025/0208135
Antibodies and Immunocytokines
Application:
62/352,291 →
Antibodies and Immunocytokines
Patent:
9,567,399 →
Application:
15/211,504 →
Antibodies and Immunocytokines
Patent:
9,617,338 →
Application:
15/354,971 →
Antibodies and Immunocytokines
Anti-Pd-L1 Antibodies
Application:
16/311,440 →
Publication:
US 2019/0330351
Anti-Pd-L1 Antibodies
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 28, 2015
From: EISENBACH-SCHWARTZ, MICHAL; BARUCH, KUTI; ROSENZWEIG, NETA
To: YEDA RESEARCH AND DEVELOPMENT CO. LTD
Reel/Frame 036192/0239 →
Assignment of Assignor's Interest
Oct 2, 2015
From: EISENBACH-SCHWARTZ, MICHAL; BARUCH, KUTI; ROSENZWEIG, NETA
To: YEDA RESEARCH AND DEVELOPMENT CO. LTD
Reel/Frame 036709/0515 →
Corrective Assignment to Correct the Assignee's Address, Previously Recorded at Reel: 036709 Frame: 0515. Assignor(S) Hereby Confirms the Assignment.
Oct 13, 2015
From: EISENBACH-SCHWARTZ, MICHAL; BARUCH, KUTI; ROSENZWEIG, NETA
To: YEDA RESEARCH AND DEVELOPMENT CO. LTD.
Reel/Frame 036844/0408 →
Assignment of Assignor's Interest
Jan 11, 2016
From: EISENBACH-SCHWARTZ, MICHAL; BARUCH, KUTI; ROSENZWEIG, NETA
To: YEDA RESEARCH AND DEVELOPMENT CO. LTD
Reel/Frame 037450/0903 →
Assignment of Assignor's Interest
Jul 27, 2016
From: EISENBACH-SCHWARTZ, MICHAL; BARUCH, KUTI; ROSENZWEIG, NETA
To: YEDA RESEARCH AND DEVELOPMENT CO. LTD
Reel/Frame 039274/0172 →
Assignment of Assignor's Interest
Jul 27, 2016
From: EISENBACH-SCHWARTZ, MICHAL; BARUCH, KUTI; ROSENZWEIG, NETA
To: YEDA RESEARCH AND DEVELOPMENT CO., LTD.
Reel/Frame 039274/0862 →
Assignment of Assignor's Interest
Jul 28, 2016
From: EISENBACH-SCHWARTZ, MICHAL; BARUCH, KUTI; ROSENZWEIG, NETA
To: YEDA RESEARCH AND DEVELOPMENT CO., LTD.
Reel/Frame 039280/0727 →
Assignment of Assignor's Interest
Oct 31, 2016
From: EISENBACH-SCHWARTZ, MICHAL; BARUCH, KUTI; ROSENZWEIG, NETA
To: YEDA RESEARCH AND DEVELOPMENT CO. LTD
Reel/Frame 040179/0378 →
Assignment of Assignor's Interest
Nov 24, 2017
From: EISENBACH-SCHWARTZ, MICHAL; BARUCH, KUTI; ROSENZWEIG, NETA
To: YEDA RESEARCH AND DEVELOPMENT CO., LTD.
Reel/Frame 044206/0528 →
Assignment of Assignor's Interest
Nov 24, 2017
From: EISENBACH-SCHWARTZ, MICHAL; BARUCH, KUTI; ROSENZWEIG, NETA
To: YEDA RESEARCH AND DEVELOPMENT CO., LTD.
Reel/Frame 044206/0536 →
Assignment of Assignor's Interest
Dec 12, 2018
From: EISENBACH-SCHWARTZ, MICHAL; BARUCH, KUTI; ROSENZWEIG, NETA
To: YEDA RESEARCH AND DEVELOPMENT CO. LTD
Reel/Frame 047758/0413 →
Assignment of Assignor's Interest
Dec 29, 2019
From: JENSEN, ALLAN; KROGH, BERIT OLSEN; EGEBJERG, JAN
To: H. LUNDBECK A/S
Reel/Frame 051382/0560 →
Assignment of Assignor's Interest
Dec 29, 2019
From: H. LUNDBECK A/S
To: IMMUNOBRAIN CHECKPOINT, INC.
Reel/Frame 051382/0567 →
Assignment of Assignor's Interest
Dec 29, 2019
From: EISENBACH-SCHWARTZ, MICHAL
To: YEDA RESEARCH AND DEVELOPMENT CO., LTD.
Reel/Frame 051382/0572 →
Assignment of Assignor's Interest
Dec 29, 2019
From: YOLES, ESTER; DAVID, CAROL; BARUCH, KUTI
To: IMMUNOBRAIN CHECKPOINT, INC.
Reel/Frame 051382/0553 →
Assignment of Assignor's Interest
Feb 26, 2021
From: EISENBACH-SCHWARTZ, MICHAL; BARUCH, KUTI; ROSENZWEIG, NETA
To: YEDA RESEARCH AND DEVELOPMENT CO. LTD.
Reel/Frame 055431/0171 →
Assignment of Assignor's Interest
Mar 2, 2021
From: JENSEN, ALLAN; KROGH, BERIT OLSEN; EGEBJERG, JAN
To: H. LUNDBECK A/S
Reel/Frame 055453/0962 →
Assignment of Assignor's Interest
Mar 2, 2021
From: YOLES, ESTER; DAVID, CAROL; BARUCH, KUTI
To: IMMUNOBRAIN CHECKPOINT, INC.
Reel/Frame 055453/0877 →
Assignment of Assignor's Interest
Mar 2, 2021
From: EISENBACH-SCHWARTZ, MICHAL
To: YEDA RESEARCH AND DEVELOPMENT CO. LTD.
Reel/Frame 055453/0987 →
Assignment of Assignor's Interest
Mar 2, 2021
From: H. LUNDBECK A/S
To: IMMUNOBRAIN CHECKPOINT, INC.
Reel/Frame 055454/0134 →
Assignment of Assignor's Interest
Apr 15, 2021
From: H. LUNDBECK A/S
To: IMMUNOBRAIN CHECKPOINT, INC.
Reel/Frame 055927/0251 →
Assignment of Assignor's Interest
Apr 15, 2021
From: EISENBACH-SCHWARTZ, MICHAL
To: YEDA RESEARCH AND DEVELOPMENT CO. LTD.
Reel/Frame 055927/0136 →
Assignment of Assignor's Interest
Apr 15, 2021
From: JENSEN, ALLAN; KROGH, BERIT OLSEN; EGEBJERG, JAN
To: H. LUNDBECK A/S
Reel/Frame 055927/0103 →
Assignment of Assignor's Interest
Apr 15, 2021
From: YOLES, ESTER; DAVID, CAROL; BARUCH, KUTI
To: IMMUNOBRAIN CHECKPOINT, INC.
Reel/Frame 055926/0947 →
Assignment of Assignor's Interest
Feb 8, 2024
From: YOLES, ESTER; DAVID, CAROL; BARUCH, KUTI
To: IMMUNOBRAIN CHECKPOINT, INC.
Reel/Frame 066415/0838 →